Nuhoglu Kantarci E, Tolgay E, Eskazan AE. Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient. Cancer 2023 Jul 3. doi: 10.1002/cncr.34938.
PMID: 37395503